Welcome to our dedicated page for Allstate SEC filings (Ticker: ALL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Allstate Corporation filings document the insurer's operating results, Regulation FD updates, governance matters and registered capital structure. Recent Form 8-K reports include quarterly and annual financial results, investor supplements, estimated catastrophe losses and policies in force for Allstate Protection.
Allstate's proxy materials describe board matters, executive compensation and shareholder voting items. Its filing cover pages identify common stock, fixed-to-floating subordinated debentures due 2053, and depositary shares representing Series H, Series I and Series J noncumulative preferred stock registered on public exchanges.
Allstate Corporation’s Chief Financial Officer John E. Dugenske reported equity-award related transactions in company common stock. On February 13, 2026, he acquired 19,588 shares at a price of $0.0000 per share through the conversion of a 2023 performance stock award under The Allstate Corporation 2019 Equity Incentive Plan.
On the same date, 7,976 shares were disposed of at $207.5100 per share to satisfy tax withholding obligations tied to that award conversion, rather than an open-market sale. After these transactions, he directly held 44,608 common shares, with an additional 338 shares held indirectly through a 401(k) plan.
Allstate Corporation executive Christine M. DeBiase, EVP, CLO and General Counsel, reported equity compensation activity in company common stock. On February 13, 2026, she acquired 11,624 shares through the conversion of a 2023 performance stock award under The Allstate Corporation 2019 Equity Incentive Plan. On the same date, 5,554 shares were withheld to cover tax obligations related to this conversion, leaving her with 11,261.904 common shares held directly after these transactions.
ALLSTATE CORP executive Mark Q. Prindiville reported equity compensation activity involving company common stock. He acquired 7,233 shares at no cost through the conversion of a 2023 performance stock award under The Allstate Corporation 2019 Equity Incentive Plan. To cover related tax withholding obligations, 2,513 shares were disposed of at a price of $207.51 per share. After these transactions, he directly owned 26,994 common shares, a net increase of 4,720 shares.
Allstate Corp executive Elizabeth Brady reported equity compensation activity involving company common stock. She acquired 8,912 shares of common stock on February 13, 2026 at $0.00 per share through the conversion of a 2023 performance stock award under The Allstate Corporation 2019 Equity Incentive Plan.
On the same date, 3,256 shares were disposed of at a price of $207.51 per share to satisfy tax withholding obligations related to that award conversion. Following these transactions, she directly held 27,666 common shares and indirectly held 202 shares through a 401(k) plan.
Allstate Corp filed a Form 13F reporting its institutional equity holdings. The report lists 699 information-table entries with an aggregate value of $7,320,757,738. The filing shows 2 other included managers: Allstate Investment Management Co and Allstate Investments LLC. The report is signed by Alexandra Band, Senior Vice President & CFO Investment Finance, dated 02-06-2026.
The Allstate Corporation executive Christine M. DeBiase reported routine equity compensation activity in company stock. On February 3, 2026, previously awarded restricted stock units converted into 2,538 shares of Allstate common stock at $0 exercise price under the 2019 Equity Incentive Plan. To cover tax withholding, 1,071 shares of common stock were withheld or disposed of at a price of $201.77 per share. After these transactions, DeBiase directly owned 5,191.904 shares of Allstate common stock.
The Allstate Corporation Chairman, President and CEO Thomas J. Wilson reported multiple open-market sales of Allstate common stock on February 2, 2026. The transactions, coded as sales, covered blocks of 1,605, 1,572, 13,271 and 359 shares at weighted average prices between $198.7714 and $201.5107, with actual trade prices ranging from $198.23 to $201.655.
These sales were executed under a Rule 10b5-1 trading plan adopted on June 27, 2025. After the reported sales, Wilson directly owned 77,601.303 Allstate common shares and also had indirect beneficial holdings through several GRATs, a 401(k) plan, and a remainder trust.
The Allstate Corporation filed a current report to furnish its press release announcing financial results for the fourth quarter and full year of 2025. The company also furnished a fourth quarter 2025 investor supplement, both as exhibits to the report, providing more detailed financial and operating information.
Allstate Corporation director Monica J. Turner reported an equity award transaction. On 02/01/2026, 456 restricted stock units converted into 456 shares of Allstate common stock at a price of $0.00 per share under the 2017 Equity Compensation Plan for Non-Employee Directors.
Following the conversion, Turner directly owns 456 shares of Allstate common stock and no longer holds the 456 restricted stock units, reflecting a shift from derivative to outright share ownership rather than a market sale or purchase.
The Allstate Corporation filed a Form 8-K to inform investors that its December 2025 monthly release is available. This release provides estimated catastrophe losses and the number of policies in force, giving insight into recent claims activity and current insurance exposure.
The company states that the release is posted on allstateinvestors.com and is also included as Exhibit 99 to this report. The exhibit is furnished, not filed, under Regulation FD, meaning it is meant for broad public disclosure rather than updating certain legal filings.